Status:
UNKNOWN
LRRK2 G2385R Leucocyte and Urine Biomarker Study
Lead Sponsor:
University of Malaya
Collaborating Sponsors:
Michael J. Fox Foundation for Parkinson's Research
University of Dundee
Conditions:
Parkinson Disease
Eligibility:
All Genders
18+ years
Brief Summary
Given the emerging evidence on LRRK2-related biomarkers, this project will focus on identifying leucocyte and urine biomarkers that are altered by the LRRK2 G2385R variant, and investigating the effec...
Eligibility Criteria
Inclusion
- Diagnosis of Parkinson's disease assigned by a movement disorder specialist according to clinical diagnostic criteria
- Age above 18 year-old
- Provision of a written informed consent
Exclusion
- \- Physical or mental incapacity to complete study protocol
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2022
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04436848
Start Date
June 1 2020
End Date
June 30 2022
Last Update
June 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Malaya Medical Centre
Kuala Lumpur, Malaysia, 50603